|
by Anthony Roberts - Letrozole (Femara) is
a type II (non-steroidal) third generation aromatase
inhibitor. Clinically it is used to treat postmenopausal
women with either estrogen receptor positive or
estrogen receptor unknown breast cancer.
In women, tumors that contain estrogen receptors
are classified as estrogen receptor-positive (ER+)
tumors. For Letrozole to be prescribed, a given
tumor must have been diagnosed as estrogen receptor
positive or estrogen receptor unknown.
In the world of bodybuilding it is used to reduce
or eliminate excess estrogen caused by the use of
aromatizing steroids.
Background
Letrozole was originally sold under the brand
name Femara, and produced by the pharmaceutical
house Novartis. It was patented on July 25th,
1997.
Action
Letrozole is known as a type II aromatase inhibitor,
meaning, in simplest terms that it attaches to the
aromatase enzyme and prevents it from converting
androgens to estrogen. In slightly more complex
terms, estrogens are produced by the conversion
of androgens through the activity of the aromatase
enzyme, and letrozole actually inhibits the production
of estrogens in by competitive, (reversible) binding
to the heme of the relevant cytochrome P450 unit.
Technical Data
Letrozole is currently the most powerful aromatase
inhibitor available. In women with breast cancer,
it has been shown to reduce estrogen levels by 98%
or more (1). However, it’s use and benefits are
not limited to eliminating estrogen in women.
In one male test subject Letrozole was able to
reduce estrogen levels to undetectable levels (2),
and in another clinical study done on both young
and elderly men, intravenous administration of Letrozole
lowered Estrogen by 46% in the young men tested,
and 62% in the elderly subjects. Because estrogen
is part of the negative feedback loop of the HPTA,
Letrozole (and other anti-estrogens) are able to
raise testosterone in male subjects. Letrozole was
studied in men, and found to significantly increase
LH levels to a 339 and 323% in the young and the
elderly, respectively and Testosterone by 146 and
99%, respectively. (3) Letrozole was also able to
produce a peak LH response to Gonadatropin Releasing
Hormone equal to a 152 and 52% increase from baseline
in either young or older men, respectively (3).
In a similar study 0.02 mg of Letrozole increased
testosterone by 45% after 2 days. (4) That same
twenty micrograms of Letrozole was also enough,
in one study done on men, to reduce estrogen levels
by roughly a third. (4)
Letrozole has a 2-4 day half-life, and it needs
to be taken for up to 60 days to get a steady blood
plasma level (5).
Letrozole was used in a rodent study to effectively
destroy (benign) breast tissue tumors (6), which
may potentially indicate its use in males attempting
to remove gynecomastia (aka gyno).
As estrogen is also a factor in stopping linear
bone growth, Letrozole is currently being examined
for potential use in delay of growth seen in children.
User Notes
In the world of bodybuilding where more is often
thought to be better, Letrozole stands almost alone
as an exception to that rule. Estrogen is necessary
for healthy immune function, healthy cholesterol
levels, joint health, cognitive function, and even
aids in muscle growth. In my own experience as well
as the experience of many bodybuilders and athletes
I’ve worked with, Letrozole simply causes estrogen
to be reduced to levels too low to function properly.
Personally, I suffered a near career-ending knee
injury while using 2.5mgs a day of this stuff, and
had one of the worst (and longest) bout with the
flu I’ve ever had. In my own particular case, I
had been using it to eliminate gyno (which it did).
I started at a dose of 2.5mgs/day and reduced it
by .25mgs every week until the gyno showed no signs
of coming back. Unfortunately, this compromised
my immune system and joint integrity.
For most recreational steroid users, Letrozole
is going to be too harsh, and cause too many problems.
Still, people can use it effectively if they don’t
use the manufacturer’s clinical dose (2.5mgs) and
instead keep their dose to .25-1mg. There are, however,
better choices for an anti-estrogen. I should mention
that using Letrozole at such a low dose does happen
to make it a very good economic choice compared
with other aromatase inhibitors.
For pre-contest bodybuilders, Letrozole is almost
a necessity to eliminate water retention and achieve
the ripped look necessary to compete in today’s
bodybuilding world. However, in my experience, it
is only necessary to be used for the last 4-6 weeks,
to eliminate excess estrogen and water retention.
After using Letrozole I recommend staying away from
any estrogen suppression for at least a month to
try to normalize the body.
Letrozole is the chemical name of active
ingredient in Femara. Femara is a registered
trademark of Novartis Pharmaceuticals Corporation
in the United States and/or other countries.
Letrozole Resources
Femara Prescribing Information
|

|
| Trivial Name |
Letrozole |
| Systematic Name |
4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile |
| CAS mumber |
112809-51-5 |
| ATC Code |
L02BG04 |
| Merck Index Number |
17890 |
| Chemical Formula |
C17H11N5 |
| Molecular Weight |
285.303 |
| Bioavailability |
99.9 |
| Metabolism |
Hepatic |
| Elimination Half Life |
2-4 days |
| Excretion |
Urinary |
| Legal Status |
Controlled (note: available
as a research chemical) |
References
- Clin Cancer Res. 2005 Apr 15;11(8):2809-21.
- Epilepsy Behav. 2004 Apr;5(2):260-3
- J Clin Endocrinol Metab. 2005 Oct;90(10):5717-22.
Epub 2005 Jul Comparative assessment in young
and elderly men of the gonadotropin response
to aromatase inhibition. T'Sjoen GG, Giagulli
VA, Delva H, Crabbe P, De Bacquer D, Kaufman
JM.
- Open dose-finding study of a new potent
and selective nonsteroidal aromatase inhibitor,
CGS 20 267[Letrozole], in healthy male subjects
PF Trunet, P Mueller, AS Bhatnagar, I Dickes,
G Monnet and G White. Research and Development
Department, CIBA-GEIGY Limited, Basel, Switzerland.
- Clin Cancer Res. 2003 Jan;9(1 Pt 2):468S-72S.
Department of Endocrinology, Ghent University
Hospital, De Pintelaan 185, 9000 Ghent, Belgium
- J Steroid Biochem Mol Biol. 2001 Dec;79(1-5):27-34.
Aromatase overexpression transgenic mice model:
cell type specific expression and use of letrozole
to abrogate mammary hyperplasia without affecting
normal physiology
Bodybuilding eBooks
America's Nuremberg -
Human Experimentation in Anabolic Steroid Research
Beyond Steroids by Anthony Roberts - The Newest and Most Effective Bodybuilding
Drugs
Burn the
Fat, Feed the Muscle by Tom Venuto - Secrets of the World's Best Bodybuilders
& Fitness Models
Chemical Muscle Enhancement by Author L Rea - Bodybuilder's Desk Reference
Chemical Wizardry by George Spellwin - The Definitive Anabolic Steroid and
Physique Enhancement Database
The Layman's Guide
to Steroids - Mick Hart's Anabolic Steroid Guides
Muscle Building Nutrition by Will Brink - Serious Lean Muscle Gains without
the Bodyfat
|